Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0000905148-24-001558 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-20 | 2024-05-16 | ATRA | Hyllengren Eric J | EVP, CFO | S - Sale | $0.62 | -28.6K | 645.7K | -4% | -$17.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | S | D | 28,648 | $0.62 | 645,671 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2024 and May 17, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. |